Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD. Hao Q, Guyatt G. Ann Intern Med 2021;174:JC10.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hao Q, Guyatt G. Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD. Ann Intern Med 2021;174:JC10.
PMID: 33395336